Jack West, MD of Swedish Cancer Institute explains how anti-PD-L1 and PD-1 therapies are being combined with chemotherapy and targeted therapy for lung cancer treatment at the 2017 Annual Meeting Annual Meeting in Chicago, IL.
Combining anti-PD-L1/PD-1 therapies with chemotherapy and targeted therapies in lung cancer treatment
